← Back to Treatments
🏅 FDA Orphan Designation

Prolastin

Alpha1-proteinase inhibitor (human)

Manufacturer: Bayer Corporation

Indicated for:
Alpha-1-antitrypsin deficiencyOrphan

FDA-Approved Indications (1)

For chronic replacement therapy of individuals having congenital deficiency of alpha1- proteinase inhibitor with clinically demonstrable panacinar emphysema.

Indications & Usage

For chronic replacement therapy of individuals having congenital deficiency of alpha1- proteinase inhibitor with clinically demonstrable panacinar emphysema.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.